Swiss Startup Atlas Bio Raises $12.5M to Simulate Drug Trials
Atlas Bio, founded in 2024, trains an AI model on human RNA data to run virtual trials. Creandum led the round.
Atlas Bio, founded in 2024, trains an AI model on human RNA data to run virtual trials. Creandum led the round.
The London robotics startup has 11 employees. It trains its model only in simulated environments and aims to teach robots a task from one demonstration.
Lette, which builds AI software for residential property operators, closed a $6.5 million seed round led by Peak and plans to enter more European markets in 2027.
A Bill going to Cabinet this week would let the State-backed lender HBFI finance zoned land for small home-builders before planning permission is granted.
Arsalan Tavakoli-Shiraji says startups lose enterprise deals by trusting their technology to sell itself. He named partnerships, four buyer concerns about AI and legacy systems as the ways in.
A survey of 247 Seattle businesses by the Seattle Metro Chamber and Downtown Seattle Association points to public safety, taxes and fees as the top problems.